Discover 3,622 paid clinical trials in Orange County, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Orange County offers clinical trials for a variety of conditions, including high blood pressure, heart disease, and skin disorders such as eczema, alopecia, and psoriasis. The city’s medical institutions are actively recruiting both healthy volunteers, as well as those with specific health needs to participate in studies that could improve treatments and outcomes for these, and many other widespread health issues.
Filter
2
Filter results
Results: 3,622
Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System
for
Type 2 Diabetes Mellitus, Type 1 Diabetes Mellitus
Location: Los Angeles CA, Santa Barbara CA, Aurora CO, Houston TX,
Sponsor: Insulet Corporation
Sex: All
Age: 14 - 70+
Code: NCT07579702
Recruiting
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: Irvine CA, Duarte CA, Los Angeles CA, Phoenix AZ,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07258511
Phase 3, Recruiting
Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma
Location: Irvine CA, Tucson AZ, Nampa ID, Meridian ID, Boise ID,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT04840602
Phase 2, Recruiting
A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)
for
Multiple Myeloma
Location: Irvine CA, Duarte CA, Denver CO, Chicago IL,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT07409246
Phase 1, Recruiting
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAK
for
Macular Edema Secondary to Inflammation
Location: Pasadena CA, Glendale CA, Los Angeles CA, Redlands CA,
Sponsor: Kodiak Sciences Inc
Sex: All
Age: 18+
Code: NCT06990399
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
for
Esophageal Squamous Cell Carcinoma,
Location: Irvine CA, Duarte CA, West Valley City UT, Spokane WA,
Sponsor: IDEAYA Biosciences
Sex: All
Age: 18+
Code: NCT07503808
Phase 1, Recruiting
Study of Plozasiran in Adults With Severe Hypertriglyceridemia at Risk of Acute Pancreatitis
for
Severe Hypertriglyceridemia
Location: Los Angeles CA, Santa Clarita CA, Seattle WA,
Sponsor: Arrowhead Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06880770
Phase 3, Recruiting
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
for
Prostate Cancer
Location: Los Angeles CA, La Jolla CA, San Diego CA,
Sponsor: AstraZeneca
Sex: Male
Age: 18+
Code: NCT06952803
Phase 3, Recruiting
A Long Term Follow-up Study of TScan TCR-T Products
for
AML, ALL, MDS
Location: Duarte CA, New York NY
Sponsor: TScan Therapeutics, Inc.
Sex: All
Age: 18 - 70+
Code: NCT06976736
Recruiting
ORION-1: Study of AVZO-023 as a Single Agent and in Combination With AVZO-021, and/or Endocrine Therapy in Advanced Solid Tumors
for
HR+/HER2- Breast Cancer, HR+, HER2-, Advanced Breast Cancer
Location: Los Angeles CA, New Haven CT, Orlando FL, Tampa FL,
Sponsor: Avenzo Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06998407
Phase 1, Phase 2, Recruiting
AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions
for
Coronary Arterial Disease (CAD),
Location: Los Angeles CA, Thousand Oaks CA, La Jolla CA,
Sponsor: Boston Scientific Corporation
Sex: All
Age: 18+
Code: NCT06959524
Recruiting
A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
for
Non Small Cell Lung Cancer, Advanced Non Small Cell Lung Cancer,
Location: Irvine CA, Goodyear AZ, Portland OR, Temple TX,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07154290
Phase 2, Recruiting
Study of GB-4362 With Enfortumab Vedotin and Pembrolizumab for Advanced Urothelial Cancer
Location: Irvine CA, Duarte CA, Houston TX, Zion IL, Tucker GA,
Sponsor: Generate Biomedicines
Sex: All
Age: 18+
Code: NCT07484022
Phase 1, Recruiting
Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Treated Multiple Myeloma
for
Multiple Myeloma
Location: Irvine CA, Duarte CA, Houston TX, Milwaukee WI,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT07555938
Phase 3, Recruiting
Adding a Live Biotherapeutic Product (CBM588) to Pembrolizumab for the Treatment of Renal Cell Cancer After Surgery
for
Clear Cell Renal Cell Carcinoma,
Location: Irvine CA, Duarte CA
Sponsor: City of Hope Medical Center
Sex: All
Age: 18+
Code: NCT07037004
Phase 2, Recruiting
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
for
Myeloproliferative Neoplasms
Location: Irvine CA, Nashville TN, Atlanta GA, Columbus OH,
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT07441694
Phase 1, Recruiting
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
for
Thyroid Gland Nodule
Location: Duarte CA
Sponsor: City of Hope Medical Center
Sex: All
Age: 19+
Code: NCT03676647
Recruiting
A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-034/MK-6482-034)
for
Carcinoma, Renal Cell
Location: Irvine CA, Duarte CA, Dallas TX, St Louis MO,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07489495
Phase 3, Recruiting
A Study Evaluating the Prophylactic Use of Tocilizumab to Prevent Cytokine Release Syndrome With Ramantamig Administration in Participants With Relapsed/Refractory Multiple Myeloma
for
Multiple Myeloma
Location: Irvine CA, Beverly Hills CA, Goodyear AZ, Palo Alto CA,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07589634
Phase 2, Recruiting
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
for
Small Cell Lung Cancer
Location: Irvine CA, Duarte CA, Goodyear AZ, Eugene OR,